Effect of intraoperative methadone vs other opioids on postoperative outcomes: a meta-analysis of randomized

Thomas Cheriyan1,2, Mohamed Gaber2, Taylor Glenn3

  • 1Summit Spine and Joint Center, Lawrenceville, GA, United States.

Pain
|June 10, 2021
PubMed

Insights

Intraoperative methadone did not significantly reduce postoperative opioid use compared to other opioids. While pain scores were lower at 24 hours, evidence for its widespread use remains insufficient.

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Evidence-Based Medicine

Background:

  • Randomized controlled trials comparing intraoperative methadone with other opioids have yielded limited and conflicting results.
  • Small sample sizes in previous studies hinder definitive conclusions on efficacy and safety.

Purpose of the Study:

  • To conduct a meta-analysis of randomized controlled trials comparing intraoperative methadone with opioid control groups.
  • To evaluate the impact of intraoperative methadone on postoperative outcomes, including opioid consumption, pain scores, and adverse events.

Main Methods:

  • Meta-analysis of nine randomized controlled trials involving 632 patients.
  • Statistical analysis performed using RevMan with a significance level of P < 0.05.
  • Primary outcomes: postoperative opioid consumption, time to first analgesic, pain scores. Secondary outcomes: extubation time, nausea, vomiting, respiratory depression.

Main Results:

  • No statistically significant reduction in postoperative opioid consumption was observed between methadone and control groups.
  • Pain scores within 24 hours were significantly lower with methadone (P = 0.002), but no difference was found between 24 and 72 hours.
  • No significant differences were found in time to first analgesic, extubation time, nausea, vomiting, or respiratory depression.

Conclusions:

  • Current evidence is insufficient to support the routine use of intraoperative methadone over other opioids.
  • While methadone may offer short-term pain relief, its long-term benefits and impact on overall opioid consumption require further investigation.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
602
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
541
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.0K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.8K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
426
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
367